BOSTON — An extended detection of window of 30/40 intervals to detect arrhythmias safely and successfully decreased the number of inappropriate shocks in patients with implantable cardioverter defibrillators, according to results from the ADVANCE III trial presented at the Heart Rhythm Society’s 33rd Annual Scientific Sessions.
Maurizio Gasparini, MD, of IRCCS Istituto Clinico Humanitas, Rozzano-Milano, Italy, and colleagues conducted a prospective, parallel, randomized, single blind study of 1,903 primary and secondary prevention patients. All were implanted with a Medtronic device from 2008 to 2010.
More »